Cargando…
Neutralizing antibodies targeting the SARS‐CoV‐2 receptor binding domain isolated from a naïve human antibody library
Infection with SARS‐CoV‐2 elicits robust antibody responses in some patients, with a majority of the response directed at the receptor binding domain (RBD) of the spike surface glycoprotein. Remarkably, many patient‐derived antibodies that potently inhibit viral infection harbor few to no mutations...
Autores principales: | Bell, Benjamin N., Powell, Abigail E., Rodriguez, Carlos, Cochran, Jennifer R., Kim, Peter S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980507/ https://www.ncbi.nlm.nih.gov/pubmed/33586288 http://dx.doi.org/10.1002/pro.4044 |
Ejemplares similares
-
Identification of an anti–SARS–CoV-2 receptor-binding domain–directed human monoclonal antibody from a naïve semisynthetic library
por: Parray, Hilal Ahmad, et al.
Publicado: (2020) -
Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies
por: Yuan, Meng, et al.
Publicado: (2021) -
Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domain
por: Gao, Xingsu, et al.
Publicado: (2022) -
Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain
por: Chi, Xiaojing, et al.
Publicado: (2020) -
Protocol for constructing large size human antibody heavy chain variable domain (V(H)) library and selection of SARS-CoV-2 neutralizing antibody domains
por: Chen, Chuan, et al.
Publicado: (2021)